The Cooper (MIL:1COO) Beta: N/A (As of Jul. 02, 2026)


MIL:1COO The Cooper Companies Inc MIL:1COO
68 GF Score
Price €61.84
GF Value €86.80
Valuation Modestly Undervalued
! 3 Warning Signs
View Full Analysis

What is The Cooper Beta?

Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. As of today (2026-07-02), The Cooper's Beta is Not available.


The Cooper  (MIL:1COO) Beta Explanation

Beta is a measure of the volatility, or systematic risk, of a security or a portfolio in comparison to the market as a whole. We usually compare beta to 1. A beta of 1 indicates that the security's price will move with the market. A beta of less than 1 means that the security will be less volatile than the market. A beta of greater than 1 indicates that the security's price will be more volatile than the market.

Beta is primarily used in the Capital Asset Pricing Model (CAPM) to calculate the Cost of Equity, which can be used in the calculation of WACC %. The formula of Cost of Equity is:
Cost of Equity = Risk-Free Rate of Return + Beta of Asset * (Expected Return of the Market - Risk-Free Rate of Return)


The Cooper Beta Related Terms


The Cooper Beta Historical Data

* Premium members only.

The historical data trend for The Cooper's Beta can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The Cooper Beta Chart

The Cooper Annual Data
Trend Oct16 Oct17 Oct18 Oct19 Oct20 Oct21 Oct22 Oct23 Oct24 Oct25
Beta
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

The Cooper Quarterly Data
Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24 Jul24 Oct24 Jan25 Apr25 Jul25 Oct25 Jan26 Apr26
Beta Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
MIL:1COO
68GF Score
The Cooper Companies Inc MIL:1COO
Beta is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

The Cooper Beta Calculation

Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. A stock's beta can be calculated by dividing the product of the covariance of the individual stock's returns and the market's returns by the variance of the market's returns over a specified period. Basically, GuruFocus uses the returns calculated over three-year period.

Is The Cooper (MIL:1COO) Overvalued in 2026?

Based on GuruFocus' analysis, The Cooper stock appears to be undervalued. The current stock price of €61.84 is trading 28.8% below its estimated GF Value™ of €86.80. GuruFocus considers The Cooper to be Modestly Undervalued.

Key valuation signals for MIL:1COO:

  • Beta: N/A
  • GF Value™: €86.80 vs. price of €61.84 (28.8% below fair value)
  • GF Score™: 68/100 with 3 warning signs

No single metric tells the full story. See the MIL:1COO stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


The Cooper Business Description

Address 6101 Bollinger Canyon Road, Suite 500, San Ramon, CA, USA, 94583
CooperCompanies is one of the largest eyecare companies in the US. It operates in two segments: CooperVision and CooperSurgical. CooperVision is a pure-play contact lens business with a suite of spherical, multifocal, and toric contact lenses. The company also has one of the most comprehensive specialty lens portfolios in the world. With brands including Proclear, Biofinity, MyDay, and Clariti, Cooper controls roughly one fourth of the US contact lens market. CooperSurgical, founded in 1990, is made up of equipment related to reproductive care, fertility, and women's care. Cooper has the broadest medical device coverage of the entire IVF cycle. It also has Paragard, the only hormone-free IUD in the US, and controls 17% of the US IUD market.
68GF Score

Get the complete analysis for MIL:1COO

Beta is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€61.84
Price
€86.80
GF Value